Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States

Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 ...